abstract |
The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising the compounds and methods of using the compositions for the treatment of various diseases, conditions and disorders. The present invention also provides a process for preparing the compounds of the present invention. The compounds of the invention and their pharmaceutically acceptable compositions may be used in various diseases, disorders such as autoimmune diseases, inflammatory diseases, proliferative diseases, or hyperproliferative diseases, neurodegenerative diseases, or immune-mediated diseases. Or useful for treating or preventing symptoms. |